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Abstract
Background: Extracts of Hypericum perforatum (St. John’s wort) have been traditionally recommended for a wide
range of medical conditions, in particular mild-to-moderate depression. The present study was designed to
investigate the effect of Hypericum perforatum treatment in a mouse model of anxiety/depressive-like behavior,
induced by chronic corticosterone administration.
Methods: CD1 mice were submitted to 7 weeks corticosterone administration and then behavioral tests as Open
Field (OF), Novelty-Suppressed Feeding (NSF), Forced Swim Test (FST) were performed. Cell proliferation in
hippocampal dentate gyrus (DG) was investigated by both 5-bromo-2’-deoxyuridine (BrdU) and doublecortin (DCX)
immunohistochemistry techniques and stereological procedure was used to quantify labeled cells. Golgi-
impregnation method was used to evaluate changes in dendritic spines in DG. Hypericum perforatum (30 mg/Kg)
has been administered for 3 weeks and then neural development in the adult hippocampus and behavioral
changes have been examined.
Results: The anxiety/depressive-like state due to chronic corticosterone treatment was reversed by exogenous
administration of Hypericum perforatum; the proliferation of progenitor cells in mice hippocampus was significantly
reduced under chronic corticosterone treatment, whereas a long term treatment with Hypericum perforatum
prevented the corticosterone-induced decrease in hippocampal cell proliferation. Corticosterone-treated mice
exhibited a reduced spine density that was ameliorated by Hypericum perforatum administration.
Conclusion: These results provide evidence of morphological adaptations occurring in mature hippocampal
neurons that might underlie resilient responses to chronic stress and contribute to the therapeutic effects of
chronic Hypericum perforatum treatment.
Background
Extracts of Hypericum perforatum (St. John’s wort) have
been traditionally recommended for a wide range of
medical conditions [1]. The most common modern-day
use of St. John’s wort is the treatment of depression [2].
In this respect, different controlled trials have confirmed
its efficacy in the treatment of mild-to-moderate depres-
sion [3]. In addition, several studies indicated that
Hypericum perforatum demonstrated anxiolytic and
anti-inflammatory effects [4,5]. Hypericum extract con-
tains numerous compounds with documented biological
activity such as the naphthodianthrones hypericin and
pseudohypericin, a broad range of flavonoids including
hyperoside, isoquercitrin and quercetin, and the phloro-
glucinols hyperforin and pseudohyperforin [6]. With
regard to this, Muller et al. [7] have demonstrated that
Hypericum perforatum inhibits the reuptake of several
synaptosomal neurotransmitters such as serotonin, nora-
drenaline, dopamine, with efficiencies similar to that
affinity selective inhibitors [8] and modulates neuronal
excitability via glutamatergic and GABAergic mechan-
isms [4]. Nevertheless, the function of Hypericum
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ulating affective behaviours remain still unclear. For
instance, basic, behavioral, and clinical evidences indi-
cate various neuroendocrine, autonomic, and behavioral
adaptative responses (resilience) to acute and chronic
stress that are critical to the occurrence of anxious and
depressive illnesses [9,10]. Moreover, changes in hippo-
campal plasticity are important biomarkers of stress
response and adaptation and play a remarkable role in
both pathogenesis of mood disorders and mechanisms
of action of antidepressants [11,12]. Stress causes altera-
tions in hippocampal networks, including altered pat-
terns of neurogenesis and remodeling of dendrites
[13,14]. In the adult brain, progenitor cells in the sub-
granular zone (SGZ) can give rise to newborn neurons
which can migrate into the granule cell layer where they
differentiate into granular neurons and are then func-
tionally integrated into the hippocampal circuitry
[15,16]. Chronic stress and direct corticosterone admin-
istration in animal models, decreases adult hippocampal
neurogenesis [17-20] and increased apoptosis of newly
generated neurons in the hippocampus [21]. In addition,
chronic stress and in-vivo corticosterone administration
induced dendritic morphological changes in the CA3
region of the hippocampus [20-24]. There is growing
evidence that many of these chronic stress-induced
structural changes in the hippocampus can be reversed
by antidepressant treatment [27-29]. Hence, in this
study we aimed to further investigate the antidepres-
sant-like and antianxiety-like activity of Hypericum per-
foratum extract using a chronic stress model in mice. In
particular we attempted to ascertain whether Hypericum
perforatum might revert the effects of corticosterone
administration on hippocampal progenitor cell prolifera-
tion and dendritic spine density and explored the beha-
vioral correlations.
Methods
Animals
Adult male CD1 mice (Harlan Nossan, Milan, Italy)
were housed four to five per cage and in a 12 h (7:00
AM to 7:00 PM) light-dark cycle at 21 ± 1°C and 50 ±
5% humidity with food and water available ad libitum.
All corticosterone - treated mice were 7-8 weeks old
and weighed 25-36 g at the beginning of the treatment.
Mice were acclimated to the behavioral room at for
2 hours prior the testing. Behavioral tests were adminis-
tered during the light phase and were conducted in
compliance with the NIH (National Institutes of Health)
laboratory animal care guidelines. The animal protocol
was approved by the Institutional Animal Care and Use
Committee (Council directive # 87-848, October 19,
1987, Ministère de l’A g r i c u l t u r ee td el aF o r ê t ,S e r v i c e
Vétérinaire de la Santé et de la Protection Animale,
permission # 92-256 to D.J.D.). Animal care was in com-
pliance with Italian regulations on protection of animals
used for experimental and other scientific purposes
(D.M. 116192) as well as with the EEC regulations (O.J:
of E.C.L 358/1 12/18/1986).
Drugs and treatment schedule
Corticosterone and BrdU (5-Bromo-2’-deoxyuridine)
were purchased from Sigma Aldrich (Milan, Italy).
Hypericum perforatum methanolic extract was a kind
gift of Indena (Milan, Italy) and it was defined by the
producer as containing 0.34% of hypericin, 4.1% of
hyperforin, 5% of flavonoids (rutin, kaempferal, luteolin,
myricetin, quercetin, quercitrin, and isoquercitrin), 10%
tannins, and the remaining by maltodextrins.
Mice were first randomized into 2 groups (N = 16 ani-
mals/group). The first group was treated with vehicle
(0.9% NaCl plus 10% DMSO) and considered as control
(non-stessed mice). The second group (CORT+) was
given corticosterone (35 μg/ml/day, equivalent to 5 mg/
Kg/day) available ad libitum in the drinking water in
opaque bottles to protect it from light, for 7 weeks
(stressed mice). After 4 weeks treatment mice were ran-
domly assigned to four different conditions: CORT-/
Vehicle (N = 8 mice); CORT-/Hypericum perforatum
(N = 8 mice); CORT+/Vehicle (N = 8 mice); CORT+/
Hypericum perforatum (N = 8 mice). Hypericum perfor-
atum was prepared every day and dissolved in minimum
volume of dimethyl sulfoxide (DMSO) plus saline solu-
tion (0.9% NaCl) with the final working concentration
of 30 mg/Kg body weight. The final volume of DMSO
in the H. perforatum vehicle was less than 10%. Daily
intraperitoneal injections of Hypericum perforatum
(30 mg/Kg body weight) or saline were performed for
3 weeks. The route of administration and dose were
chosen in according to the study by Di Paola et al. [5].
Behavioral tests were performed before the treatments,
after 4 weeks (CORT- and CORT+ groups) and 7 weeks
(CORT-/Vehicle, CORT-/Hypericum perforatum, CORT
+/Vehicle, CORT+/Hypericum perforatum). Mice were
injected with BrdU (150 mg/Kg, i.p.) dissolved in saline
and scarified after 2 hours (Figure 1).
Fur state and body weight
Mice were inspected and weighted daily for a week
before the CORT treatment, during the following
4 weeks of CORT treatment and during the Hypericum
perforatum treatment. The condition of their fur was
scored once a week by two independent observers
blinded. Scores were averaged over the treatment peri-
ods for each animal. The coat-state evaluation involved
the assessment of eight different body parts: head, neck,
dorsal coat, ventral coat, tail, forepaws, hind paws and
genital region. For each body area, a score of 0 was
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for a dirty coat. The total score was defined as the sum
of the scores for each body part (Griebel 2002) [30].
Behavioral assessments
Open field (OF)
Locomotor activity was monitored for 5 min in an open
field, a white Plexiglas box 50 × 50 cm with its floor
divided into 16 squares. Four squares were defined as
the center and 12 squares along the walls as the periph-
ery. Each mouse was gently placed in the center of the
box and activity was scored as a line crossing when a
mouse removed all four paws from one square and
entered another. Before each trial, the chamber was
cleaned with water containing a detergent. The animals’
behaviour was videotaped. The line crossings and the
time spent in the center were counted and scored.
Novelty suppressed feeding test (NSF)
The test was carried out during a 5 min period as pre-
viously described [31]. Briefly, the testing apparatus con-
sisted of a plastic box (50 × 50 × 20 cm), the floor was
covered with 2 cm of wooden bedding. Twenty-four
hours before behavioral testing, animals were deprived
of all food in the home cage. At the time of testing, a
single pellet of food was placed on a white paper plat-
form positioned in the center of the box. The test began
started after the animal was placed in a corner of
the box. The measure of interest was scored when
the mouse was sitting on its haunches and biting with
the use of forepaws. After this test, mice were trans-
ferred to their home cage and the amount of food con-
sumed in 5 min was measured.
Forced swim test (FST)
The test is based on that described by Porsolt et al. [32].
A vertical glass cylinder (25 cm high, 14 cm in dia-
meter) was filled with 27°C water to a depth of 20 cm.
Each mouse was gently placed in the cylinder for 6 min
and the duration of floating (i.e. the time during which
mice made only the small movements necessary to keep
their heads above water) was scored. Immobility time
was analyzed during the last 4 min period of the test.
Immunohistochemistry
After the brain was fixed for 1 week fixation at room
temperature in buffered formaldehyde solution (10% wt/
vol in PBS), samples were dehydrated in graded ethanol
and embedded in Paraplast (Sherwood Medical, Mah-
wah, NJ). Thereafter, 7-μm sections were deparaffinized
with xylene and rehydrated. BrdU and DCX analysis was
carried out after boiling in 0.01 M citrate buffer for
4 min. Endogenous peroxidase was quenched with 0.3%
(vol/vol) hydrogen peroxide in 60% (vol/vol) methanol
for 30 min. Non-specific adsorption was minimized by
incubating the section in 2% (vol/vol) normal goat
serum in PBS for 20 min. Endogenous biotin or avidin
binding sites were blocked by sequential incubation for
15 min with biotin and avidin (DBA, Milan, Italy),
respectively. Sections were incubated overnight with 1)
mouse monoclonal anti-BrdU antibody (1:100 in PBS,
wt/vol) and with 2) goat polyclonal anti-Doublecortin
antibody (Santa Cruz, California, USA ). Sections were
washed with PBS and incubated with the secondary
antibody. Specific labelling was detected with a biotin-
conjugated goat anti-rabbit IgG and avidin-biotin perox-
idase complex (DBA). The counterstain was carried out
with nuclear fast red (red background). All sections
were observed using light microscopy at 40X magnifica-
tion (Axostar Plus equipped with Axio-Cam MRc,
Zeiss) and studied via Imaging computer program
(Axio-Vision, Zeiss). Quantitative evaluations was car-
ried out on color monitor. For each experiment nine
sections (three sections per mice) were selected for ana-
lysis. For each section, the numbers of immunopositive
cell for correspondinf antibodies were counted in den-
tate gyrus (DG).
Golgi impregnation
FD Neurotech kit (FD NeuroTechnologies, Ellicott City,
Md, USA) was used for Golgi impregnation of tissue.
Blocks were placed directly into solutions A and B,
without rinsing, and remained there for 2 weeks in the
dark at room temperature. Forty-eight hours after pla-
cing in solution C (4°C), the blocks were frozen on dry
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GROUP 2 Hyp.p
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Figure 1 Experimental design. CD1 mice were administered
during 7 weeks with vehicle or corticosterone in the presence or
absence of Hypericum perforatum during the last three weeks of the
corticosterone regimen. At the end of treatment the animals were
tested in the behavioral paradigm and then sacrificed for
neurogenesis study.
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tions (100 μm )w e r ec u ta t- 2 5 ° Ca n dm o u n t e do n t o
gelatinized slides. Slides were allowed to dry in the dark,
and the rest of the staining process done as previously
described [33]. Neurons were chosen for the analysis if
completely impregnated with Golgi stain and unobs-
cured by other impregnated neurons or precipitant.
Moreover 70% of the dendritic tree was visible within
the plane of focus and dentate granule neurons must be
located in the outer one-half of the granule cell layer in
DG. Cells chosen for analysis had to be well impreg-
nated, clearly distinguishable from adjacent cells and
have continuous unbroken dendrites. Spines were
counted under oil (X100), using light microscopy (Axos-
tar Plus equipped with Axio-Cam MRc, Zeiss), and the
entire visible dendritic length measured by Imaging
computer program (Axio-Vision, Zeiss). Spine density
was calculated referring to the length of the dendrite.
Statistical Analysis
All values in the figures and text are expressed as mean
± standard error of mean (S.E.M.) of N observations.
For the in vivo studies N represents the number of ani-
mals studied. For all experiments two-way ANOVA was
applied. Significant interactions were resolved using post
hoc ANOVAs with adjusted p value.
Results
Behavioral mesurements
Alterations in coat state were observed at the end of the
corticosterone treatment in the presence or absence of
3w e e k sHypericum perforatum. Deterioration of the
coat state, altered body weight, increased drinking and
f o o dc o n s u m p t i o nw e r ep r o v o k e db yal o n gt e r m
administration of exogenous corticosterone. These para-
meters were not significantly re-established under
Hypericum perforatum treatment (30 mg/Kg/day) for
3 weeks (Figure 2). Exogenous administration of corti-
costerone developed an anxiety-like phenotype in the
OF and NSF but not in FST. In particular, with regard
to the OF, an evident decrease on the time spent in the
center of arena was seen. Such alteration was then
reversed by Hypericum perforatum treatment. (Figure 3A).
The number of crossing in chronic corticosterone-treated
mice did not show significant differences compared to the
vehicle and remained unchanged after treatment with
Hypericum perforatum (Figure 3B).
In the NSF test, exogenous chronic corticosterone
administration increased the latency to feed while
chronic administration of Hypericum perforatum
reversed this anxiety phenotype (Figure 3C) without
affecting the home food consumption.
Chronic corticosterone administration had no effect in
the FST, whereas Hypericum perforatum administration
decreased the immobility time in both corticosterone-
treated and vehicle group (Figure 3D).
Immunohistochemistry results
Exogenous chronic corticosterone exposure mimicked
the effect of chronic stress on cell proliferation, decreas-
ing the number of both BrdU
+ and cells in the granule
cell layer (GCL) being then restored by 3 weeks of
Hypericum perforatum administration (Figure 4A). In
corticosterone-treated mice tracing of the apical den-
drites of DG granular cells revealed a significant reduc-
tion in the development of dendritic spines that was
reverted by Hypericum perforatum treatment (Figure
4G).
Discussion
In the present study we showed that chronic corticoster-
o n et r e a t m e n t ,s i m i l a r l yt ow h a tp r e v i o u s l yr e p o r t e db y
David et al. [20], induces an affective phenotype which
was reversed by chronic administration of the Hyperi-
cum perforatum. The pre-treatment with corticosterone
leads to a deterioration of the state of the coat that can
not be reversed by chronic Hypericum perforatum
administration. For instance, an anxiogenic effect was
observed in CORT+ mice in the OF and the NSF. This
effect was reversed by Hypericum perforatum treatment.
In addition, CORT+ mice showed deficit in hippocam-
pal progenitor cell proliferation and a reduced number
of CA3 dendritic spines which were prevented by Hyper-
icum perforatum chronic treatment.
Consistent with previous findings [20], our beha-
vioural data demonstrate that increased corticosterone
levels induce anxiety in CD1 mice as assessed by the
decreased time in the center of the arena in OF para-
digm and by the increase in latency to feed in NSF. Cor-
ticosterone-treated mice did not show depression-like
phenotype in the FST. Hypericum perforatum adminis-
tration significantly ameliorated the anxiety-like pheno-
type (OF and NSF) in CD1 mice. Our data are in
accordance with those reporting an anti-anxiety effect
induced by Hypericum perforatum administration in
models of restrain stress and sleep deprivation [34,35].
Studies conducted by Flausino et al. and Singewald et al.
[36,37] have shown that chronic administration of
Hypericum perforatum induced an antidepressant-like
effect in Mg-depleted mice in the forced swim test, as
well as anxiolytic-like effects in both anxiety tests. In
our study, we used a different chronic stress paradigm
and performed different behavioral paradigms (OF and
NSF). Nonetheless, our data further reaffirm a role for
Hypericum perforatum in helping to cope with different
stressful conditions.
The synaptic correlates of this anti-anxiety effect are
still a matter of debate. There is some preliminary
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Figure 2 Changes in the physiological parameters after corticosterone and Hypericum perforatum treatment.( A , B )4w e e k s
corticosterone treatment induced deterioration of the coat state (C) Mouse body weight of each animal was monitored during 4 weeks
corticosterone (35 μg/ml/day) and Hypericum perforatum (30 mg/Kg) treatment (3 weeks). Values plotted are mean ± SEM (N = 8 per group).
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* p < 0.05 versus vehicle group.
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Page 5 of 10evidence of the mode of action of Hypericum extract
such as inhibition of uptake of serotonin (5-HT), nora-
drenaline, dopamine [8,38-42]. Based on the previous
work hypericin was considered to be an inhibitor of
both MAO type A and B [43] and inhibitor of synapto-
somal reuptake of serotonin, noradrenaline and dopa-
mine [7]. Furthermore, Hypericum perforatum extract
increases extracellular levels of dopamine, noradrenaline,
serotonin in the rat locus coeruleus [8] and modulated
adenosine, GABAA,G A B A B and glutamate receptors
[39]. Nevertheless, whether these effects could account
for the in-vivo anti-anxiety properties need still to be
demonstrated.
To further verify the effects of Hypericum perforatum
on hippocampal plasticity, we carried out an experiment
on hippocampal progenitor cell proliferation. The hip-
pocampus is a region that shows a remarkable capacity
for structural reorganization. Preexisting neural circuits
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Figure 3 Effect of chronic Hypericum perforatum treatment on corticosterone-induced behavioral changes.( A )E f f e c t so f3w e e k so f
Hypericum perforatum treatment, beginning after 4 weeks of corticosterone administration, on anxiety behaviors in OF. Anxiety is calculated as
mean of the total time in the center in seconds. Exogenous chronic corticosterone treatment decreased the time spent in the center of arena.
This anxiety phenotype was reversed by chronic administration of Hypericum perforatum. Values plotted are mean ± SEM (N = 8 per group). * p
< 0.05, ° p < 0.05, § p < 0.05 versus vehicle group, corticosterone/vehicle group, and Hypericum perforatum/vehicle group, respectively. (B)
Regarding the number of crossing, cort- and cort+ mice did not show differences after chronic corticosterone administration; exogenous
Hypericum perforatum administration did not modify this parameter. Values plotted are mean ± SEM (N = 8 per group). (C) In the NSF paradigm,
exogenous chronic corticosterone administration increased the latency to feed; this phenotype was reversed by chronic administration of
Hypericum perforatum. Values plotted are mean ± SEM (N = 8 per group). * p < 0.05, ° p < 0.05, versus control group and corticosterone/vehicle
group, respectively. (D) In the FST chronic corticosterone administration had no effect, while Hypericum perforatum treatment decreased the
immobility time in both cort- and cort+ group. Values plotted are mean ± SEM (N = 8 per group). * p < 0.05, ° p < 0.05, versus control group
and corticosterone/vehicle group, respectively.
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synapse number, and entirely novel neural connections
are formed through the process of neurogenesis. Stress
exerts a significant modulation of hippocampal struc-
tural plasticity and is a potent negative regulator of neu-
rogenesis. Different chronic stress suppress the rate of
adult dentate gyrus proliferation and decreases the size
of newborn cell clusters [45]. In accordance with these
data, we found a reduction in hippocampal progenitor
cell proliferation in mice chronically treated with corti-
costerone. The effects of corticosterone administration
on neurogenesis are limitated to the proliferation stage
and not the maturation of newborn neurons. Interest-
ingly, the effect of Hypericum perforatum extract on
proliferation and maturation is more pronounced in cor-
ticosterone-treated mice than in controls. We can spec-
ulate that this model may increase the dynamic range in
which Hypericum perforatum extract exerts its effects
on different stages of neurogenesis. Adult hippocampal
neurogenesis in the adult hippocampus has been impli-
cated in cognitive function and is stimulated by antide-
pressant drugs, although its functional impact and
contribution to the aetiology of anxiety/depression is
unclear [20,45,46]. However, severe or chronic stress
exposure, both in early life as well as in adulthood,
affect hippocampal neurogenesis and plasticity [46,47].
A reduction in neurogenesis can theoretically contribute
to the cognitive symptoms of depression, even though
by itself is unlikely to produce the full mood disorder
[49]. The molecular mechanisms by which glucocorti-
coids induce these changes are however still unclear.
Conversely, we demonstrated that in corticosterone-
treated mice these changes are reverted by 3 weeks
Hypericum perforatum administration.
Hypericum perforatum administration reverted the
negative effect of stress on dendritic spine in mature hip-
pocampal neurons. Dendritic spines are small specialized
membranous protrusions that contain the postsynaptic
machinery (PSD, glutamate receptors, cytoskeleton) and
play a crucial role in synaptic plasticity [50] and calcium
signaling [51-53]. Dynamic changes in spine number and
morphology are closely linked to changes in strength of
synaptic connections [54]. It has been suggested that a
derangement of spine dynamics that favors loss of spines
is a candidate mechanism for stress-evoked dendritic
atrophy and associated synaptic dysfunction [55]. Our
data confirm the negative effects of stress on dendritic
spine number and demonstrated for the first time that
Hypericum perforatum administration significantly
decreased stress-induced dendritic pathology. Live ima-
ging studies showed that spines are remarkably dynamic,
changing size and shape and number over timescales of
seconds to minutes [56]. Stress-induced changes in neu-
rotransmitters, growth factors, hormones and oxidative
stress could be responsible for the dendritic spines struc-
tural changes (size, number and shape). For instance,
Hypericum perforatum administration significantly atte-
nuated lipid peroxidation, nitrite concentration and par-
tially restored GSH and catalase activity in chronic
restrained mice suggesting a strong antioxidant effect
[35]. In this respect, administration of fluoxetine also
reduces oxidative stress in restraint animals [57] and pro-
motes resilience. It is thus conceivable that antioxidant
properties of Hypericum perforatum m a yb ep r o t e c t i v e
against the deleterious effects of chronic stress on hippo-
campul dendritic spines.
Conclusion
This study establishes a previously unknown framework
underlying both resilience and anti-anxiety action of
Hypericum perforatum. Our results provide evidence of
morphological adaptations occurring in both newborn
and mature hippocampal neurons that might underlie
resilient responses to chronic stress and that might con-
tribute to the therapeutic effects of chronic Hypericum
perforatum treatment.
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